ATAI | Investor Presentation Deck | 49 slides · page 21 of 49
The slide highlights positive cognitive signals from a Phase 2 study, specifically emphasizing the efficacy of lower doses of RL-007.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 6/6
chart 2/2 disclaimer 1/1 source-note 1/1 title 2/2
Components 6
bar-vertical bar-vertical disclaimer source-note action-title headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.